Brad Tade Biography and Net Worth

CFO & Treasurer of ADMA Biologics

Mr. Tade is the Chief Financial Officer & Treasurer of ADMA Biologics. He joined the company in June 2023 as Vice President of Financial Operations. Before joining ADMA, Mr. Tade served as Vice President of Finance for Commercial Packaging Technology and Development and Manufacturing at PCI Pharma Services. Prior to that, he held the role of Vice President of Finance for Operations & Quality at Baxter in Illinois and Vice President of Operations Finance at Becton Dickinson in Switzerland. With over 20 years of experience in the medical device industry, Mr. Tade has led global supply chain and manufacturing operations finance teams across multiple countries and multinational organizations.

He holds a Bachelor of Science degree in Finance from California State University, Long Beach, and a Master of Arts degree in Organizational Leadership from Gonzaga University.

What is Brad L. Tade's net worth?: The estimated net worth of Brad L. Tade is at least $4.04 million as of November 22nd, 2024. Mr. Tade owns 199,433 shares of ADMA Biologics stock worth more than $4,040,513 as of March 29th. This net worth evaluation does not reflect any other investments that Mr. Tade may own. Learn More about Brad L. Tade's net worth.
How do I contact Brad L. Tade?: The corporate mailing address for Mr. Tade and other ADMA Biologics executives is 465 STATE ROUTE 17, RAMSEY NJ, 07446. ADMA Biologics can also be reached via phone at (201) 478-5552 and via email at info@admabio.com. Learn More on Brad L. Tade's contact information.
Has Brad L. Tade been buying or selling shares of ADMA Biologics?: Brad L. Tade has not been actively trading shares of ADMA Biologics in the last ninety days. Most recently, Brad L. Tade sold 15,000 shares of the business's stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $21.15, for a transaction totalling $317,250.00. Following the completion of the sale, the chief financial officer now directly owns 199,433 shares of the company's stock, valued at $4,218,007.95. Learn More on Brad L. Tade's trading history.
Who are ADMA Biologics' active insiders?: ADMA Biologics' insider roster includes Steve Elms (Director), Bryant Fong (Director), Adam Grossman (Co-Founder, President, CEO & Director), Jerrold Grossman (Director), Lawrence Guiheen (Director), Kaitlin Kestenberg-Messina (COO), Young Kwon (Director), Brian Lenz (CFO), and Brad Tade (CFO & Treasurer). Learn More on ADMA Biologics' active insiders.
Are insiders buying or selling shares of ADMA Biologics?: During the last year, insiders at the biotechnology company sold shares 7 times. They sold a total of 581,900 shares worth more than $9,613,370.88. The most recent insider tranaction occured on November, 22nd when CFO Brad L Tade sold 15,000 shares worth more than $317,250.00. Insiders at ADMA Biologics own 3.7% of the company. Learn More about insider trades at ADMA Biologics.
Information on this page was last updated on 11/22/2024.

Brad L. Tade Insider Trading History at ADMA Biologics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/22/2024	Sell	15,000	$21.15	$317,250.00	199,433

Brad L. Tade Buying and Selling Activity at ADMA Biologics

ADMA Biologics Company Overview

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Today's Range

Now: $20.26

$19.72

$20.63

50 Day Range

MA: $17.13

$15.44

$20.61

2 Week Range

Now: $20.26

$5.90

$23.64

Volume

2,360,170 shs

Average Volume

3,517,452 shs

Market Capitalization

$4.79 billion

P/E Ratio

72.36

Dividend Yield

N/A

Beta

0.6